Back
Blueprint Medicines 10K Form
Buy
55
BPMC
Blueprint Medicines
Last Price:
91.35
Seasonality Move:
11.38%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-26 | 10Q | BPMC/Blueprint Medicines Quarterly |
| 2023-08-02 | 10Q | BPMC/Blueprint Medicines Quarterly |
| 2023-05-04 | 10Q | BPMC/Blueprint Medicines Quarterly |
| 2022-11-01 | 10Q | BPMC/Blueprint Medicines Quarterly |
| 2022-08-02 | 10Q | BPMC/Blueprint Medicines Quarterly |
| 2022-05-03 | 10Q | BPMC/Blueprint Medicines Quarterly |
Receive BPMC News And Ratings
See the #1 stock for the next 7 days that we like better than BPMC
BPMC Financial Statistics
Sales & Book Value
| Annual Sales: | $249.38M |
|---|---|
| Cash Flow: | $-83.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.14 |
| Price / Book: | 43.65 |
Profitability
| EPS (TTM): | -8.36000 |
|---|---|
| Net Income (TTM): | $-506.98M |
| Gross Margin: | $240.84M |
| Return on Equity: | -161.12% |
| Return on Assets: | -43.47% |
Blueprint Medicines Earnings Forecast
Key Blueprint Medicines Financial Ratios
- The Gross Profit Margin over the past 9 years for BPMC is 96.58%.
- The Selling, General & Administrative Expenses for BPMC have been equal to 118.35% of Gross Profit Margin.
- The Research & Development expenses have been 171.51% of Revenue.
- The Interest Expense is -0.03% of Operating Income.
- The Net Earning history of BPMC is -203.30% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 5 years.
Blueprint Medicines Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BPMC |
| CUSIP: | 09627Y |
| Website: | blueprintmedicines.com |
Debt
| Debt-to-Equity Ratio: | 1.83 |
|---|---|
| Current Ratio: | 3.76 |
| Quick Ratio: | 3.51 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BPMC Technical Analysis vs Fundamental Analysis
Buy
55
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy or a Sell?
-
Blueprint Medicines stock is rated a Buy
The current Blueprint Medicines [BPMC] share price is $93.10. The Score for BPMC is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.